Medisys PLC (MDY) Providing innovative solutions to the rapidly growing point-of-care diagnostic and healthcare worker safety markets. For more than 35 years, companies in the Medisys group have been advancing healthcare through development, manufacture and distribution of revolutionary medical products. The Group's mission is to become a leading worldwide provider of diagnostic systems and medical safety products enabling rapid, cost effective, on-site delivery of healthcare solutions.
For more than three decades, Medisys' primary operating unit, Hypoguard, has been devoted to advancing personal and professional healthcare management. The Company's core focus is diabetes glucose self-monitoring - a rapidly growing market of nearly $5 billion worldwide.
'Medisys-group.com'
'Hypoguard.com'

15/02/2006
Medisys reported a 'considerable improvement' in trading during the first four months of its financial year, and said the business has been cash-flow neutral for the year to date.
The medical products company said competition in its core long-term care blood glucose monitoring business has not intensified. A drop in sales amid intense competition in the market caused a fall in sales and profits last year.
Sales volumes have recovered to previous highs by cutting prices and offering various promotions, Medisys reported this morning.
Margin improvements have been achieved faster than originally anticipated, it added. The company has benefited from cost saving measures implemented in the second half of the last financial year and cost reductions for its proprietary biosensor products.
Meanwhile, it has completed the development and manufacturing scale up of the first of the new systems it has designed for Menarini, the fifth largest worldwide branded marketer of blood glucose monitoring systems.
While the launch date is not yet clear, (Around March 1) Medisys predicted that sales of the products will be one of its key revenue growth drivers in the current financial year.


LATEST ON MDY V'S ROCHE COURT CASE
MDY V'S ROCHE COURT CASE Case IS Dismissed. http://www.moneyam.com/InvestorsRoom/posts.php?tid=8721#lastread
My apologies for any one that was on MDY it looks like we have been stitched up like a kipper the sale of Hypoguard blood glucose monitoring business at that price looks like an sp of 3p against the close of 6.4p what can I say no one could have seen this coming a total sell out and that is what I have done.

A very nice 1m buy and 1/2m just gone through this share is starting to pick up.

We have lift off 25% up.

Oh bugger.

KEAYDIAN
I take it your not in, there is still time buy on the drop MDY is a fast recovering stock back to 15p to 25p where it belongs IMO.

Watching in the background Driver but have limited access to a PC today.

Good pick, Driver (again). I have no spare at the moment, but I am jealous to death of your picking abilities.
Good luck all,
Alan

Al
Sell your BBC and get on board, but don't say I told you if it goes tits up.

:-)

When is launch date of new product driver,any specific date.

Alan-Driver are you not in DGT??--very good company and still cheap so check it out.

mbugger
No I do not have a date for the official launch of MDYS new product, see marksp's post below.

Driver
Glucomen Visio is not launched. "Balance" magazine is produced every 2 months. The ads had to be included even though the product is not on general sale yet in the retail market. menarini UK don't have stock for retail and they still consider it as unannounced which is why the websites don't feature it.

The ad you have on this thread is being leeched from my website. I am going to move it at the weekend, can you arrange for it to me rehomed for your thread.

MDY cannot issue the RNS until menarini launch so we all sit and wait

Good luck to all here

M

In case anyone is interested

AGM = 26 April in deepest Suffolk.

bring your own teeth and sheep

9p short term target

marksp
Thanks for your fleeting visit from advfn with your expert knowledge of MDY as you say we must wait for the official launch of Glucomen Visio, in the mean time we are enjoying the ride.

Takeover or no takeover MDY is on solid ground with the end of the cc and new product launch this is what is moving the sp bid speculation is only the cherry on the cake.

From the Guardian today March 10

Among the smaller stocks, Medisys, which makes and sells blood glucose monitoring devices in the US, was up 0.3p at 6.45p after several days of gains. Some speculated that the group could be the subject of a takeover approach from its larger rival Menarini, with which it signed a product development strategic alliance last year.

Menarini have some very strong contacts

http://www.nhshealthquality.org/nhsqis/files/evidence_note8.pdf

I cant believe I missed the boat on this. Is there a 12 month guidance on this?

I'm hoping we're heading back towards the 1.40 the sp was back before the troubles-it's looking good!! I intend to keep adding when I can anyone agree??

Thesaurus
You havent missed the boat MDY have not yet officially launched their new product there is plenty of upside to come.